Due to the COVID pandemic, more people across the United States are working from home than ever before, approximately 25-30% of the workforce. While there are some bonuses like no commuting in traffic and working in your sweatpants, a major downside has developed: new or worsening neck and back pain. The most logical culprit is makeshift home offices that are not ergonomically correct. Not everyone has the luxury of a designated home office. In the U.S., back pain is a leading cause of missed days at work and school. Without proper care, approximately 20% of people with acute lower-back pain will have persistent symptoms within a year. To add insult to injury, many are afraid to seek outside care for fear of exposing themselves to people during the pandemic.
PRODUCT DETAILS
Get back-popping, knot-kneading relief
Effortlessly release low back tension
Roll out headaches and neck pain
Sleep better by relaxing tight muscles
PRODUCT DESCRIPTION
The Chirp Wheel is designed to fit perfectly between your shoulder blades, targeting the muscles that go up and down your spine. As your back is strained from the countless activities you do, those muscles lock up, and cause even more pain. The Chirp Wheel massages those muscles, relaxing your back and relieving all of the pain.
What age range is Chirp Appropriate For? Chirp’s customers range from 18-80. The Wheels can even hold up to 500 lbs, so it's built 100% PVC free and won't break. If your back pain is the result of a serious accident or injury, please consult a doctor first.
How often should one use the Chirp Wheel +
It is recommended that the Chirp Wheel+ is used for 5-10 minutes a day, or as needed. The Chirp Wheel+ is designed to reduce tension, target knots, and help 'open' your vertebrae. Be patient. Your body may need some time to decompress the spine and relax all those tight muscles."
The 3 Problems with Other Back Pain Relief Solutions:
1. They are expensive. Chiropractors are a good option, but feeling like you have to see one every week costs far more in time and money than the Chirp Wheel. In fact, the company has a network of over 3,000 Chiropractors and Physical Therapists that recommend the wheel, especially in-between visits.
2. They don't fit where you need them to. Foam rollers can't put the pressure in the right places to really relieve the pain. The Chirp Wheel has a Patent Pending Spinal Canal™ and Compression Sensitive™ padding to ensure comfort and relief.
3. They don't store well. Inversion tables take up half the living room, and it's impossible to fit a foam roller in your bag when you are on the go. The Chirp Wheel is lightweight and travels easy!
A Difference You Can Feel
Relaxing 4-way stretch with their patented Spinal Canal™
Deep tissue massage with our ergonomic design
Lasting relief with only 5 minutes of rolling out
Sleep better by relaxing tension in your neck, upper back, and lower back
COVID-19 Contributes to Uptick in Opioid-Related Deaths
Baltimore, MD, September 21, 2020 — Social isolation and reduced access to healthcare during the lockdown, among other factors, have led to a rise in opioid-related deaths, experts say. And according to their estimates, it’s only going to get worse. Similarly, Authorities acrossTexas, Pennsylvania, Florida and New York are also reporting rises in overdoses during the COVID-19 crisis.
On the frontlines working to curb the impact of the opioid crisis is Dr. Paul Christo, anAssociate Professor in the Division of Pain Medicine at the Johns Hopkins University School of Medicine.
"The number of fatalities from opioid-related overdoses could be nearly 30 percent higher than reported due to missing information or incomplete death records,” he says. “The worst fear is that because of social isolation, and people are not being found or treated immediately."
The opioid epidemic today progressed in three phases, according to the Centers for Disease Control and Prevention. The first involves deaths caused by prescription opioids, the second, an increase in heroin use, and the third, a surge in the use of synthetic opioids or fentanyl. Experts say the U.S. is right in the middle of the third phase of the epidemic, due to the increasing availability of fentanyl and increasing rates of overdose deaths involving synthetic opioids.
According to a recent study there were 632,331 drug overdoses between 1999 and 2016. Most of these deaths (78.2 percent) were drug overdoses with known drug classification. Moreover, 21.8 percent were unclassified drug overdoses. A further investigation revealed that for unclassified drug overdoses, 71.8 percent involved opioids, translating to 99,160 additional opioid-related deaths.
There were over 70,000 drug overdose deaths in 2017, according to an estimate from the CDC. Based on findings from the new study, over half of those deaths — about 47,000 — are suspected of having involved opioids.
Another study on opioid overdoses found that the number of drug overdose deaths decreased by 4 percent from 2017 to 2018. In 2018, more than 67,000 people died from drug overdoses, making it a leading cause of injury-related death in the United States. Almost 70 percent involved a prescription or illicit opioid of those deaths.
“COVID 19 impacted the drug supply chain by closing borders on some regions, and it led to the higher death rate,” Dr. Christo explained. He added that drugs become more challenging to get, and the potency of overdose goes up. It also impacts the price, everything goes up, and in that sense, it becomes more deadly each day, according to Dr. Christo.
About Dr. Paul Christo
Dr. Paul Christo serves as Director of the Multidisciplinary Pain Fellowship Program at Johns Hopkins Hospital. He is the author of Aches and Gains, A Comprehensive Guide to Overcoming Your Pain. Dr. Paul Christo also hosts an award-winning, nationally syndicated SIRIUS XM radio talk show on overcoming pain called, Aches and Gains®. For more information about Dr. Paul Christo. Please visit www.paulchristomd.com.
Mitsubishi Tanabe Pharma Canada Announces Treatment for Amyotrophic Lateral Sclerosis (ALS) now Eligible for Coverage through Veterans Affairs Canada and Indigenous Services Canada
TORONTO, Sept. 21, 2020 /CNW/ - Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA), announced today that RADICAVA® (edaravone), an infusion treatment for amyotrophic lateral sclerosis (ALS), is now reimbursed by Veterans Affairs Canada (VAC) and Indigenous Services Canada via the Non-Insured Health Benefits (NIHB) Program.
"We would like to thank Veterans Affairs Canada and Indigenous Services Canada for providing eligible ALS patients access to this treatment," said Atsushi Fujimoto, President, MTP-CA. "Including RADICAVA on these formularies is an important step to support those living with ALS who are eligible under the federal programs."
In addition to VAC and NIHB, RADICAVA is also listed on the:
Régie de l'assurance maladie du Québec (RAMQ) formulary (special authorization)
Ontario Drug Benefit Formulary (Exceptional Access Program)
Alberta Drug Benefit List (special authorization)
New Brunswick Drug Plan (NBDP) formulary (special authorization)
Manitoba Drug Benefits and Interchangeability Formulary (special authorization)
Saskatchewan Formulary (special authorization)
Nova Scotia Drug Formulary (special authorization)
British Columbia (BC) PharmaCare Formulary (special authorization)
MTP-CA continues to have discussions with other provinces regarding the listing of RADICAVA under additional publicly funded drug programs.
About RADICAVA® (edaravone) RADICAVA (edaravone) is indicated to slow the loss of function in patients with amyotrophic lateral sclerosis (ALS), as measured by the ALS Functional Rating Scale - Revised (ALSFRSR).1 Edaravone was discovered and developed for ALS by Mitsubishi Tanabe Pharma Corporation (MTPC) through an iterative clinical development platform over a 13-year period. In 2015, edaravone was approved for use as a treatment for ALS in Japan and South Korea. RADICAVA was approved by the U.S. Food and Drug Administration in May of 2017. Marketing authorization was granted in Canada in October 2018 and Switzerland in January 2019.
About Mitsubishi Tanabe Pharma Canada, Inc. Based in Toronto, Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA) with a goal to provide therapies for some of the most difficult-to-treat diseases, including ALS. For more information, please visit www.mt-pharma-ca.com.
About Mitsubishi Tanabe Pharma America, Inc. Based in Jersey City, N.J., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation's (MTPC) 100 percent owned U.S. holding company, Mitsubishi Tanabe Pharma Holdings America, Inc. MTPA is dedicated to delivering innovative products that address the unmet medical needs of patients in North America. It was established by MTPC to commercialize approved pharmaceutical products in North America with plans to expand its product line through collaborations with partners. For more information, please visit www.mt-pharma-america.com.
Sunnybrook launches the Dr. Sandra Black Centre for Brain Resilience & Recovery with $10-million gift
TORONTO, Sept. 21, 2020 /CNW/ - On World Alzheimer's Day – dedicated to raising awareness about the devastating impact that Alzheimer's and other dementias have on countless lives worldwide – Sunnybrook is pleased to announce a generous and timely investment from a local philanthropist who chooses to remain anonymous.
This $10-million gift launches the Dr. Sandra Black Centre for Brain Resilience & Recovery at Sunnybrook. The Centre is named in honour of renowned Sunnybrook neurologist Dr. Sandra Black, whose vast contributions to the field of brain health and tremendous ability as a physician inspired the donor to make a lead investment.
With this donation, the Centre is set to lead the way with novel and innovative approaches to support brain resilience that will eventually help the brain recover from these challenging neurological conditions.
"During the unprecedented global crisis of the COVID-19 pandemic, it's important to continue fighting back against another threat to global health, which is Alzheimer's and dementia," says Dr. Andy Smith, Sunnybrook's President and CEO. "We couldn't be more grateful for this generous investment, and we're honoured that the donor has named the Centre after such a gifted physician, scientist, mentor and leader. I know that Dr. Black and her team will continue to be on the cutting edge of research and push the limits in search of solutions to the world's most challenging brain conditions to help improve the lives of patients and their families."
The Centre builds on years of research and unites Sunnybrook's internationally recognized team of dementia experts to attack Alzheimer's and dementia from multiple angles. From investigating biology, therapeutics and risk factors to analyzing big data, Dr. Black's team will seek answers to questions that have hindered progress in treating these disorders to date.
With resources for the Centre, Dr. Black can keep this world-class team at Sunnybrook, where together they are building an extensive volume of research focusing on uncovering the relationship between the brain's microvasculature — the complex, intricate network of small blood vessels — and dementia.
"The relationships among neurovascular disease, aging and dementia are incredibly complex – and a complex disease calls for a multi-faceted approach," says Dr. Sandra Black, inaugural director of the new Centre. "There have been some recent advances in diagnosing dementia, but so far no effective treatments exist. Our aim with this Centre is to help change that by better understanding why some brains are more resilient than others, promoting brain-healthy lifestyle choices, and controlling risk factors such as high blood pressure and diabetes. Our goal is to slow decline and support a personalized recovery. The earlier we intervene, the more we can build on each individual's resilience, regardless of age."
With initial support from the lead donation and the ongoing efforts of Sunnybrook Foundation to reach the Centre's $30-million goal, Sunnybrook's uniquely collaborative team of dementia researchers will have the resources they need to find ways to prevent and treat Alzheimer's and dementia. Without having to wait for annual funds from granting agencies, this gift gives Dr. Black and her team the ability to conduct longer-term research studies and accelerate the pace of this groundbreaking work.
"This is a prime example of the power of philanthropy to advance an important field of medicine, even during a global pandemic," says Dr. Jon Dellandrea, President and CEO of Sunnybrook Foundation. "These resources both secure the legacy of a researcher and clinician who has had a tremendous impact on understanding brain health, and ensure that this legacy of discovery will continue well into the future. The impact of this generous investment will be incalculable as our global population continues to age."
Sunnybrook Health Sciences Centre is inventing the future of health care for the 1.3 million patients the hospital cares for each year through the dedication of its more than 10,000 staff and volunteers. An internationally recognized leader in research and education and a full affiliation with the University of Toronto distinguishes Sunnybrook as one of Canada's premier academic health sciences centres. Sunnybrook specializes in caring for high-risk pregnancies, critically ill newborns and adults, offering specialized rehabilitation and treating and preventing cancer, cardiovascular disease, neurological and psychiatric disorders, orthopaedic and arthritic conditions and traumatic injuries. The hospital also has a unique and national leading program for the care of Canada's war veterans.
SOURCE Sunnybrook Health Sciences Centre
St. Jude expert reminds parents to get children necessary HPV vaccinations
In honor of Childhood Cancer Awareness Month, stay on track with child vaccinations, advises St. Jude expert
“I am asking parents to protect their children by ensuring they get all the necessary vaccinations, including the HPV vaccine,” said Heather Brandt, Ph.D., director of the HPV Cancer Prevention Program at St. Jude Children’s Research Hospital. “The human papillomavirus (HPV) vaccination—a safe and effective vaccine that has been proven to prevent six different kinds of cancer most commonly developed in adulthood – can safeguard your child from getting cancer later in life.”
The Centers for Disease Control and Prevention (CDC) recommends four vaccines during adolescence: seasonal flu, Tdap (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis), HPV, and meningococcal conjugate. In the U.S., the first dose of Tdap and meningococcal coverage among adolescents is in the 90th percentile. Unfortunately, HPV vaccination rates are much lower. In 2019, roughly 57% of girls were up to date on HPV vaccination, and boys’ rates were 52%.
“With September both Gynecological Cancer Awareness Month and Childhood Cancer Awareness Month, this is a profound occasion for us to honor those who have these kinds of cancers and to increase awareness of these diseases,” Brandt said. “When it comes to preventing HPV-caused cancers, we have made incredible strides.”
Follow the vaccination schedule from both the CDC and the American Academy of Pediatrics, Brandt advises. The HPV vaccination is recommended at age 11–12 years and can start at age 9. The catch-up HPV vaccination is recommended for everyone through age 18. This is a two- or three-dose series depending on age at initial vaccination.
“While we do not yet have a way to prevent the pediatric cancers that afflict most of our patients at St. Jude, we can prevent HPV cancers,” Brandt said. “Talk with your child’s doctor about getting the HPV vaccine and don't miss this chance to make sure your child is protected in the future.”
Each year in the U.S., 34,800 men and women are diagnosed with an HPV-related cancer, and several hundred thousand more are diagnosed with pre-cancerous conditions (such as women having abnormal Pap tests and testing positive for HPV).
Brandt recently authored a guest opinion piece, Don’t Delay Your Child’s Vaccinations, for Newsweek highlighting the importance of child immunizations.
Francia Raisa Teams up with Silk + Sonder for a Limited Edition Wellness Journal Los Angeles, CA - September 21, 2020 - grown-ish star Francia Raisa teamed up with the BIPOC women founded, monthly subscription journal service, Silk + Sonder for a limited edition Wellness Journal launching today on Silk + Sonder's website for $20. This limited edition journal, which fuses some of Silk + Sonder's layouts with Francia's personal touch and unique tone, highlights daily practices and content curated by Francia, including a thought provoking writing exercise and more.
Imagery HERE On Why Journaling is Important to Francia:Struggling with depression and anxiety throughout her life, Francia realized the importance of journaling and how it has helped her express her emotions. The wellness side really came into focus for her when she had her kidney surgery, when the doctor said that her life would never be the same. She was determined to make her overall quality of life better than what it had been. Journaling helped her to look forward, prioritize her everyday habits and learn a lot about herself and knowing what it means to love herself. On Why Francia Chose Silk + Sonder:After meeting Silk + Sonder founder & CEO, Meha Agrawal through a mutual friend Francia instantly fell in love with her spirit, the concept of her journals and her drive towards her company. "She's a true girl boss!" Meha had such a powerful vision and passion for journaling, which made Francia feel like she was the perfect person to collaborate with. "I know that during this pandemic, people are experiencing a lot of emotions. I hope that this journal helps you to stay grounded and focus on yourself. I hope that you enjoy the journal as much as I do! I'm really excited to share this special part of myself with all of you" said Francia.
"At Silk + Sonder, we are very intentional about who we partner with and when I met Francia, I was blown away by her authenticity, humility and commitment to spread kindness. Our shared values made it an obvious and seamless partnership that we were both excited to bring to life!" says Silk + Sonder founder & CEO Meha. About SILK + SONDERSILK + SONDER is the first ever monthly journal experience aimed to empower you to live the life you've always wanted. Inspired by a new theme every month, we hand-curate, design, and deliver each issue straight to your doorstep. Each month's issue includes a blend of productivity and planning, introspection and mindfulness, and lifestyle content. Over time, we are committed to understanding your unique preferences and motivations to provide you with the most authentic experience as well as the opportunity to start afresh, every month. For more information visit, www.silkandsonder.com.
St. Michael's Hospital Foundation's Angels Den Returns with Joe Mimran, Michele Romanow and Vinay Virmani, Awarding $450,000 for COVID-19 Research and Healthcare Innovation
The sixth annual Angels Den healthcare research competition, presented by St. Michael's Hospital Foundation, is going virtual to provide world-leading scientists with the opportunity to fund game-changing research
TORONTO, Sept. 21, 2020 /CNW/ - On Wednesday, September 30th at 7:00 pm EST, Canadians are invited to tune into the online iteration of St. Michael's Hospital Foundation's Angels Den competition on YouTube. Angels Den is traditionally an in-person event hosted in Downtown Toronto but this year, due to the ongoing COVID-19 pandemic, the competition has gone completely virtual. During this hour-long special episode, six St. Michael's research teams will pitch their ground-breaking research ideas to a panel of celebrity judges, competing for prizes totaling $450,000 in research funding.
The six research teams are divided into two research streams. The first stream is focused on ideas related to COVID-19 management and solutions, and the second stream highlights other urgent healthcare challenges. The top prize for each stream of $150,000 are the Keenan COVID-19 Research Award and the Odette Innovative Health Award. Each finalist will be awarded $25,000.
This year, Canadian viewers have an important job to do. Viewers can weigh in and cast their votes online on September 30th, immediately following the episode, to share who they think should win the $50,000 People's Choice Award, presented by Canada Life.
"St. Michael's Hospital Foundation's Angels Den is a leading medical research competition in Canada, awarding one of the largest monetary prizes in the country." says Dr. Muhammad Mamdani, Vice President, Data Science and Advanced Analytics at Unity Health Toronto and previous Angels Den winner. "Amidst the COVID-19 pandemic, it's more important than ever that we are funding and supporting innovations in healthcare that will be showcased during the online Angels Den episode."
Renowned Canadian broadcast personality Maureen Holloway is hosting this year's competition. To determine the winners, three celebrity judges will weigh in to recognize and award the researchers:
Joe Mimran, retail fashion and business pioneer and founder of Joe Fresh
Michele Romanow, tech titan and Co-Founder & President of Clearbanc
Vinay Virmani, partner and chief content officer at Uninterrupted
The judges will review this year's three research projects in the COVID-19 related stream, where research teams will showcase how they are pioneering solutions to the COVID-19 pandemic that optimize hospital flow, improve treatment, stem the spread of the virus and pave the way to a vaccine. The judges will also review the second stream focused on innovative health research that offers unconventional solutions that solve some of the toughest health problems.
Canadians are encouraged to tune into this special episode of Angels Den on the foundation's website AngelsDen.ca on September 30th at 7:00 pm EST to watch the scientists pitch their research projects and cast their votes for the People's Choice Award from 8:00 pm EST to 9:00 pm EST. The winner of the People's Choice Award will be announced on social media (@stmichaelsfdn) and online (AngelsDen.ca) on Thursday, October 1, 2020.
This event would not be possible without St. Michael's Hospital Foundation's generous sponsors:
Presenting Sponsor: RBC Top Prize Sponsors: Patrick and Barbara Keenan Foundation and P. & L. Odette Charitable Foundation Show Sponsor: Rogers People's Choice Award Sponsor: Canada Life Team Biographies Sponsor: Deloitte
About St. Michael's Hospital Foundation St. Michael's Hospital, part of Unity Health Toronto, is globally renowned for its research and treatment for some of the world's toughest health challenges such as multiple sclerosis, brain aneurysms, cystic fibrosis, blindness, infectious diseases and traumatic injury. St. Michael's Hospital is recognized for its work with the most marginalized members of our community, particularly those who are disadvantaged and are experiencing homelessness. Its world-leading physicians, surgeons, scientists dig deep to find solutions to intractable medical problems. They advocate on behalf of those whose health is complicated by life circumstances. They stop at nothing.
The Fertility Partners Inc. Acquires Significant Minority Interest in Sequence46 Genetic Testing Laboratory
TORONTO, Sept. 21, 2020 /CNW/ - The Fertility Partners ("TFP") announced today that it has partnered with leading genetic testing laboratory Sequence46 in Los Angeles, California. This investment significantly expands the comprehensive services offered by its Canada-wide network of fertility clinics in the pursuit of global best IVF clinical outcomes and the healthiest babies.
The Fertility Partners works with world-class fertility clinics, providing access to shared medical, strategic and operational best practices, promoting research and development activities and offering extensive back-office support. Its goal is to foster global best clinical outcomes, an international reputation for excellence, and exceptional patient and employee experiences. The TFP partner model empowers physicians and their teams to focus on doing what they do best- provide the highest quality fertility medicine and patient services.
Says TFP's Founder, CEO & Executive Chairman Dr. Andrew Meikle, "we are very excited to partner with Catherine Welch and Sequence46, who align with our values and clinical objectives. With their evidence-based technology, we can improve the chance of pregnancy, reduce the risk of miscarriage, be more confident in transferring a single embryo (thereby avoiding health risks associated with twin or triplet pregnancies) and reduce the number of IVF cycles needed to achieve pregnancy. We see clear advantages for our patients in potentially reducing the time to pregnancy and the costs of extra cycles for our patients."
Catherine Welch, Founder and CEO of Sequence46 (S46), states, "we are thrilled for The Fertility Partners to join the Sequence46 family as we continue to grow genetic testing in the Canadian market. The leadership of The Fertility Partners is well respected, and we look forward to working closely with them. It is through collaboration, patient education and multi-site R&D with TFP that we will be able to improve access to testing and success rates of infertility treatment while offering best in class care at their network of IVF centers across the country."
Dr. Gary Nakhuda, a co-founder of Olive Fertility Centre and The Fertility Partners Manager of S46, states, "since its inception, Sequence46 has developed relationships and shared R&D with a network of the best IVF labs in North America to deliver the most innovative and cutting-edge genetic testing while providing the best value for patients. The TFP investment ushers an exciting new phase in fertility services as patients in Canada can now access the most advanced preimplantation genetic diagnostics and emerging new technologies such as non-invasive PGT-A."
About The Fertility Partners: The Fertility Partners is a new venture creating a network of respected fertility clinics across North America. The company aims to be a world-class business partner of choice for leading IVF and prenatal practitioners to achieve global best clinical outcomes, operational excellence and exceptional patient experiences. TFP provides partner clinics with back-office support and a collaborative, synergistic medical-scientific, professional and business environment. https://www.thefertilitypartners.com/
About Sequence46: Sequence46 is a Los Angeles, CA based leading CAP-certified genetic testing laboratory founded by experts in fertility, embryology and genetics, who are committed to offering comprehensive patient care using the latest science and best-in-class technology. They are extremely passionate about innovation and research in the field of reproductive genetics. The goal of S46 is to improve IVF outcomes and help families have healthy babies through their preimplantation genetic testing (PGT) offerings. https://www.sequence46.com/
SOURCE The Fertility Partners
OVER 1,600 CANADIANS VOLUNTEER TO BE DELIBERATELY EXPOSED TO CORONAVIRUS
A GROWING PETITION, SPONSORED BY MP MARCUS POWLOWSKI, CALLS ON THE GOVERNMENT TO PUBLICLY ANNOUNCE COVID-19 HUMAN CHALLENGE TRIALS
Over 1,600 Canadians have volunteered to be deliberately exposed to the coronavirus with 1Day Sooner, an organization that advocates on behalf of these “human challenge trial” volunteers. In such a trial, healthy volunteers are exposed to a virus under controlled conditions to quickly test vaccines and learn more about the disease, potentially saving tens of thousands of lives.
Now, over 150 Canadians have signed apublic petitioncalling on the Government of Canada to “publicly announce a plan for COVID-19 human challenge trials.” The petition is sponsored by MP Marcus Powlowski of Thunder Bay-Rainy River and signed by the below Canadian scientists. This comes after MP Marcus and nearly a dozen other MPs and scientists penned a Toronto Star op-ed on August 24th urging the government to green-light COVID-19 human challenge trials.
Below you can find the pictures, first names, locations, and quotes of signatories of the new petition.
###
To connect with any of the below, or any Canadian human challenge trial volunteers, or a 1Day Sooner team member,please email media@1daysooner.org
Marcus Powlowski, Member of Parliament for Thunder Bay-Rainy River
“There are few issues more important in the world right now than developing a successful vaccine for COVID-19. Governments globally should seriously consider the use of challenge trials as a way to speed up the vaccine development process and, by doing so, potentially save thousands of lives and billions of dollars in lasting economic damage."
Dr. Anand Kumar, Professor of Medicine, Medical Microbiology and Pharmacology, Sections of Infectious Diseases and Critical Care Medicine, at the University of Manitoba.
Dr. Micheal Silverman, Chair and Chief of Adult Infectious Disease at Western University
Dr. Bill Cameron, Professor of Medicine, Division of Infectious Disease, University of Ottawa at The Ottawa Hospital
Conor Barnes, 1Day Sooner volunteer from Kelowna, Canada.
“Sometimes you should take one for the team, and this is a very big team.”
Find the Career that Fits Perfectly: The Tools are at Your Fingertips
Sacramento, CA, Sept. 21, 2020 — Why do so many people stay in unrewarding careers? Fear of change? Lack of updated skills? Whatever the case, staying in an unfulfilling job prevents you from doing what you really want to do. The pandemic taught us that we can pivot and innovate faster than we ever thought possible, so why not restart your career with a renewed vision and a clearer path forward?
Elevate Your Career: Live a Life You’re Truly Proud Of from experienced career development coach Helen Horyza brilliantly demonstrates how you can design a career that aligns with your interests and talents by discovering what makes you truly happy.
“The path to a thriving career requires self reflection to discover what values are important to you and to identify the types of work that hold real meaning,” Horyza writes. “It also demands patience and persistence.”
Through a series of true stories, Horyza illustrates how people from all walks of life and education levels can create a career that is literally a perfect fit—even if you don’t know what your “passion” is yet.
In addition to these real-world examples, Elevate Your Career includes valuable tools that readers can use right away to reassess their career paths. First, the Elevate Career Cycle method, which is explained in the book, can help readers uncover their passion by pinpointing their interests and unique talents. Also included with the book is a coupon code for the Elevations Career Assessment, which synthesizes values, skills, interests and personality in the context of contemporary careers. Individuals who complete the assessment receive a focused report complete with valuable decision-making tools. The result is a comprehensive model for smart and healthy career development.
No matter where you are in your evolving career journey—college student, executive or someone looking to course-correct—this book will provide you with the tools and the momentum you need to elevate your career.
Helen Horyza is an expert in the fields of career development and employee development, engagement and retention. She is an accomplished trainer, motivational speaker and executive coach. She holds a Master of Science degree in Career Counseling from California State University, Sacramento (CSUS), and is a professionally trained coach through Coach Training International. She is a Nationally Certified Career Counselor (NCCC) and has over 20 years of experience uncovering talent and directing it to achieve extraordinary results.
Horyza is comfortable inspiring audiences large and small with her authentic, approachable style. She is the inventor and author of the Elevations® suite of assessments designed to assist individuals in career transition or to enhance employee engagement. Elevations® is utilized in colleges, universities and in consultant practices around the world.
She has used her own advice to re-career and is opening the Career Coach Entrepreneur Academy in the fall, a training program for people interested in becoming career coaches.
